Structural and functional cardiac changes in myotonic dystrophy type 1: A cardiovascular magnetic resonance study

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Hermans, Mieke Ce ^a   Faber, Catharina G ^a   Bekkers, Sebastiaan Cam ^a   De Die Smulders, Christine Em ^a   Gerrits, Monique M ^a   Merkies, Ingemar Sj ^b   Snoep, Gabriel ^a   Pinto, Yigal M ^c   Schalla, Simon ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Infection and Immunology   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac magnetic resonance imaging; Cardiomyopathy; Endomyocardial fibrosis; Myotonic dystrophy

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MAGNETIC RESONANCE; DISEASE DURATION; DISEASE SEVERITY; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE OUTFLOW TRACT; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; MYOTONIC DYSTROPHY; NUCLEOTIDE REPEAT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC DYSFUNCTION; TISSUE STRUCTURE;

ADULT; AGED; CARDIOMYOPATHIES; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOTONIC DYSTROPHY; REPRODUCIBILITY OF RESULTS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84865232642     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-48     Document Type: Article

References (31)

1. Harper PS, Myotonic dystrophy Saunders, London 3 2001
2. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Harley HG, Rundle SA, MacMillan JC, Myring J, Brook JD, Crow S, Reardon W, Fenton I, Shaw DJ, Harper PS, Am J Hum Genet 1993 52 1164 1174 8503448 (Pubitemid 23311358)
3. Age and causes of death in adult-onset myotonic dystrophy. de Die-Smulders CE, Howeler CJ, Thijs C, Mirandolle JF, Anten HB, Smeets HJ, Chandler KE, Geraedts JP, Brain 1998 121 1557 1563 10.1093/brain/121.8.1557 9712016 (Pubitemid 28349907)
4. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Mathieu J, Allard P, Potvin L, Prevost C, Begin P, Neurology 1999 52 1658 1662 10.1212/WNL.52.8.1658 10331695 (Pubitemid 29220644)
5. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Lazarus A, Varin J, Ounnoughene Z, Radvanyi H, Junien C, Coste J, Laforet P, Eymard B, Becane HM, Weber S, Duboc D, Circulation 1999 99 1041 1046 10.1161/01.CIR.99.8. 1041 10051298 (Pubitemid 29104494)
6. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, et al. N Engl J Med 2008 358 2688 2697 10.1056/NEJMoa062800 18565861 (Pubitemid 351860861)
7. Dystrophies and heart disease. Cox GF, Kunkel LM, Curr Opin Cardiol 1997 12 329 343 9243091 (Pubitemid 27252541)
8. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Bushby K, Muntoni F, Bourke JP, Neuromuscul Disord 2003 13 166 172 10.1016/S0960-8966(02)00213-4 12565916 (Pubitemid 36140013)
9. Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. Bhakta D, Groh MR, Shen C, Pascuzzi RM, Groh WJ, Am Heart J 2010 160 1137 1141 1141 e1131 10.1016/j.ahj.2010.07.032 21146669
10. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ, Am J Cardiol 2002 90 29 34 10.1016/S0002-9149(02)02381-0 12088775 (Pubitemid 34671198)
11. Aids to the examination of the peripheral nervous system Her Majesty's Stationary Office, London 1943 1 2
12. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Kleyweg RP, van der Meche FG, Schmitz PI, Muscle Nerve 1991 14 1103 1109 10.1002/mus.880141111 1745285
13. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Mathieu J, Boivin H, Meunier D, Gaudreault M, Begin P, Neurology 2001 56 336 340 10.1212/WNL.56.3.336 11171898 (Pubitemid 32144144)
14. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S, J Cardiovasc Magn Reson 2005 7 775 782 10.1080/10976640500295516 16353438 (Pubitemid 41770055)
15. Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Verhaert D, Richards K, Rafael-Fortney JA, Raman SV, Circ Cardiovasc Imaging 2011 4 67 76 10.1161/CIRCIMAGING.110.960740 21245364
16. Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imaging. De Ambroggi L, Raisaro A, Marchiano V, Radice S, Meola G, Eur Heart J 1995 16 1007 1010 7498193
17. Familial left ventricular hypertrabeculation in myotonic dystrophy type 1. Finsterer J, Stollberger C, Kopsa W, Herz 2003 28 466 470 10.1007/s00059-003-2437-4 12928748 (Pubitemid 37040100)
18. Right ventricular MR abnormalities in myotonic dystrophy and relationship with intracardiac electrophysiologic test findings: initial results. Vignaux O, Lazarus A, Varin J, Coste J, Carlier P, Argaud C, Laforet P, Weber S, Legmann P, Duboc D, Radiology 2002 224 231 235 10.1148/radiol.2241010986 12091688 (Pubitemid 34685512)
19. Myocardial Changes in Dystrophia Myotonica. Arnason G, Berge T, Dahlberg L, Acta Med Scand 1964 176 536 538 14223528
20. Dystrophia myotonica with heart block. A light and electron microscopic study. Bulloch RT, Davis JL, Hara M, Arch Pathol 1967 84 130 140 6028461
21. Cardiac abnormalities in myotonic dystrophy. Electrophysiologic and histopathologic studies. Motta J, Guilleminault C, Billingham M, Barry W, Mason J, Am J Med 1979 67 467 473 10.1016/0002-9343(79)90795-2 474592 (Pubitemid 10237032)
22. Dystrophica myotonia. Correlative electrocardiographic, electrophysiologic, and conduction system study. Bharati S, Bump FT, Bauernfeind R, Lev M, Chest 1984 86 444 450 10.1378/chest.86.3.444 6468005 (Pubitemid 14027362)
23. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. Nguyen HH, Wolfe JT, Holmes DR, Edwards WD, J Am Coll Cardiol 1988 11 662 671 10.1016/0735-1097(88)91547-1 3278037 (Pubitemid 18060228)
24. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ, Circulation 2003 108 54 59 10.1161/01.CIR.0000078641.19365.4C 12821550 (Pubitemid 36859020)
25. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ, J Am Coll Cardiol 2003 41 1561 1567 10.1016/S0735-1097(03)00189-X 12742298 (Pubitemid 36543376)
26. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, Poole-Wilson PA, Pennell DJ, J Am Coll Cardiol 2006 48 1977 1985 10.1016/j.jacc.2006.07.049 17112987 (Pubitemid 44738448)
27. Cardiac disease in myotonic dystrophy. Phillips MF, Harper PS, Cardiovasc Res 1997 33 13 22 10.1016/S0008-6363(96)00163-0 9059523 (Pubitemid 27019094)
28. Cardiac manifestations of myotonic dystrophy type 1. Petri H, Vissing J, Witting N, Bundgaard H, Kober L, Int J Cardiol 2011 Epub ahead of print
29. Relation of CTG expansion and clinical variables to electrocardiogram conduction abnormalities and sudden death in patients with myotonic dystrophy. Sabovic M, Medica I, Logar N, Mandic E, Zidar J, Peterlin B, Neuromuscul Disord 2003 13 822 826 10.1016/S0960-8966(03)00138-X 14678805 (Pubitemid 37532732)
30. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy? Clarke NR, Kelion AD, Nixon J, Hilton-Jones D, Forfar JC, Heart 2001 86 411 416 10.1136/heart.86.4.411 11559681 (Pubitemid 32889378)
31. Progression of somatic CTG repeat length heterogeneity in the blood cells of myotonic dystrophy patients. Martorell L, Monckton DG, Gamez J, Johnson KJ, Gich I, Lopez de Munain A, Baiget M, Hum Mol Genet 1998 7 307 312 10.1093/hmg/7.2.307 9425239 (Pubitemid 28048547)